Publicacions

''EXPRESSION OF ALPHA(1)-ADRENERGIC RECEPTORS IN RAT PREFRONTAL CORTEX: CELLULAR CO-LOCALIZATION WITH 5-HT(2A) RECEPTORS.''

SANTANA N, MENGOD G, ARTIGAS F,

2013

''PRECLINICAL MODELS OF SCHIZOPHRENIA''

FRAZER A, ARTIGAS F.,

2013

''RNAI-MEDIATED SEROTONIN TRANSPORTER SUPPRESSION RAPIDLY INCREASES SEROTONERGIC NEUROTRANSMISSION AND HIPPOCAMPAL NEUROGENESIS.''

FERRÉS-COY A, PILAR-CUELLAR F, VIDAL R, PAZ V, MASANA M, CORTÉS R, CARMONA MC, CAMPA L, PAZOS A, MONTEFELTRO A, VALDIZÁN EM, ARTIGAS F, BORTOLOZZI A.,

2013

''SEROTONIN RECEPTORS INVOLVED IN ANTIDEPRESSANT EFFECTS.''

FRANCESC ARTIGAS.,

2013

''SEROTONIN MODULATION OF CORTICAL NEURONS AND NETWORKS.''

CELADA P, PUIG MV, ARTIGAS F.,

2013

''PRECLINICAL AND CLINICAL CHARACTERIZATION OF THE SELECTIVE SEROTONIN-1A RECEPTOR ANTAGONIST DU-125530 FOR ANTIDEPRESSANT TREATMENT.''

SCORZA MC, LLADÓ-PELFORT L, OLLER S, CORTÉS R, PUIGDEMONT D, PORTELLA MJ, PÉREZ-EGEA R, ALVAREZ E, CELADA P, PÉREZ V, ARTIGAS F,

2012

''PRECLINICAL AND CLINICAL CHARACTERIZATION OF THE SELECTIVE 5-HT(1A) RECEPTOR ANTAGONIST DU-125530 FOR ANTIDEPRESSANT TREATMENT.''

SCORZA MC, LLADÓ-PELFORT L, OLLER S, CORTÉS R, PUIGDEMONT D, PORTELLA MJ, PÉREZ-EGEA R, ALVAREZ E, CELADA P, PÉREZ V, ARTIGAS F.,

2012

''NORADRENERGIC ANTIDEPRESSANTS INCREASE CORTICAL DOPAMINE: POTENTIAL USE IN AUGMENTATION STRATEGIES.''

MASANA M, CASTAÑÉ A, SANTANA N, BORTOLOZZI A, ARTIGAS F.,

2012

''SELECTIVE SIRNA-MEDIATED SUPPRESSION OF 5-HT1A AUTORECEPTORS EVOKES STRONG ANTIDEPRESSANT-LIKE EFFECTS.''

BORTOLOZZI A, CASTAÑÉ A, SEMAKOVA J, SANTANA N, ALVARADO G, CORTÉS R, FERRÉS-COY A, FERNÁNDEZ G, CARMONA MC, TOTH M, PERALES JC, MONTEFELTRO A, ARTIGAS F,

2012

''SELECTIVE SIRNA-MEDIATED SUPPRESSION OF 5-HT1A AUTORECEPTORS EVOKES STRONG ANTI-DEPRESSANT-LIKE EFFECTS.''

BORTOLOZZI A, CASTAÑÉ A, SEMAKOVA J, SANTANA N, ALVARADO G, CORTÉS R, FERRÉS-COY A, FERNÁNDEZ G, CARMONA MC, TOTH M, PERALES JC, MONTEFELTRO A, ARTIGAS F. ,

2012

''A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, ACTIVE REFERENCE STUDY OF LU AA21004 IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.''

ALVAREZ E, PEREZ V, DRAGHEIM M, LOFT H, ARTIGAS F.,

2012

''5-HT 1A RECEPTOR AGONISTS ENHANCE PYRAMIDAL CELL FIRING IN PREFRONTAL CORTEX THROUGH A PREFERENTIAL ACTION ON GABA INTERNEURONS.''

LLADÓ-PELFORT, L.; SANTANA, N.; GHISI, V.; ARTIGAS, F.; CELADA, P.,

2012

''DEEP BRAIN STIMULATION OF THE SUBCALLOSAL CINGULATE GYRUS: FURTHER EVIDENCE IN TREATMENT-RESISTANT MAJOR DEPRESSION.''

PUIGDEMONT D, PÉREZ-EGEA R, PORTELLA MJ, MOLET J, DE DIEGO-ADELIÑO J, GIRONELL A, RADUA J, GÓMEZ-ANSON B, RODRÍGUEZ R, SERRA M, DE QUINTANA C, ARTIGAS F, ÁLVAREZ E, PÉREZ V.,

2012

''CLOZAPINE REVERSES PHENCYCLIDINE-INDUCED DESYNCHRONIZATION OF PREFRONTAL CORTEX THROUGH A 5-HT(1A) RECEPTOR-DEPENDENT MECHANISM.''

KARGIEMAN L, RIGA MS, ARTIGAS F, CELADA P.,

2012

''EXPRESSION OF ALFA(1)-ADRENERGIC RECEPTORS IN RAT PREFRONTAL CORTEX: CELLULAR CO-LOCALIZATION WITH 5-HT(2A) RECEPTORS.''

SANTANA N, MENGOD G, ARTIGAS F.,

2012

''DOPAMINE NEUROTRANSMISSION AND ATYPICAL ANTIPSYCHOTICS IN PREFRONTAL CORTEX: A CRITICAL REVIEW.''

MASANA M, SANTANA N, ARTIGAS F, BORTOLOZZI A.,

2012

''IN VIVO ELECTROPHYSIOLOGICAL AND NEUROCHEMICAL EFFECTS OF THE SELECTIVE 5-HT1A RECEPTOR AGONIST, F13640, AT PRE- AND POSTSYNAPTIC 5-HT1A RECEPTORS IN THE RAT.''

LLADÓ-PELFORT L, ASSIÉ MB, NEWMAN-TANCREDI A, ARTIGAS F, CELADA P.,